YAP1 and intrahepatic cholangiocarcinoma: Here, we illustrated that ANLN restrains the Hippo pathway by reducing YAP1 phosphorylation level and enhancing YAP1 transcriptional activity, partly explaining the promoting-tumor effects of ANLN in ICC.